Synthesis, Characterization, and Antibacterial Activity of Structurally Complex 2-Acylated 2,3,1-Benzodiazaborines and Related Compounds

被引:37
作者
Kanichar, Divya [1 ]
Roppiyakuda, Lance [1 ]
Kosmowska, Ewa [1 ]
Faust, Michelle A. [1 ]
Tran, Kim P. [1 ]
Chow, Felicia [1 ]
Buglo, Elena [1 ]
Groziak, Michael P. [1 ]
Sarina, Evan A. [2 ]
Olmstead, Marilyn M. [2 ]
Silva, Isba [3 ]
Xu, H. Howard [3 ]
机构
[1] Calif State Univ Hayward, Dept Chem & Biochem, Hayward, CA 94542 USA
[2] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
[3] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA
基金
美国国家卫生研究院;
关键词
ENOYL REDUCTASE; BORON HETEROCYCLES; INHIBITION; MECHANISM; DERIVATIVES; TARGETS; AGENTS; ENVM;
D O I
10.1002/cbdv.201400007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A set of 2-acylated 2,3,1-benzodiazaborines and some related boron heterocycles were synthesized, characterized, and tested for antibacterial activity against Escherichia coli and Mycobacterium smegmatis. By high-field solution NMR, the heretofore unknown class of 2-acyl-1-hydroxy-2,3,1-diazaborines has been found to be able to exist in several interconvertable structural forms along a continuum comprised of an open hydrazone a, a monomeric B-hydroxy diazaborine b, and an anhydro dimer c. X-Ray crystallography of one of the anhydro dimers, 17c, revealed it to have an unprecedented structure featuring a double intramolecular O -> B chelation. The crystal structure of another compound, 37, showed it to be based on a new pentacyclic B heterocycle framework. Nine compounds were found to possess activities against E. coli, and two others were active against M. smegmatis. The finding that these two contain isoniazid covalently embedded in their structures suggests that they might possibly be acting as prodrugs of this well-known antituberculosis agent in vivo.
引用
收藏
页码:1381 / 1397
页数:17
相关论文
共 44 条
[11]   Syntheses and evaluation of benzodiazaborine compounds against M-tuberculosis H37RV in vitro [J].
Davis, MC ;
Franzblau, SG ;
Martin, AR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (07) :843-846
[12]   Molecular genetic analysis of enoyl-acyl carrier protein reductase inhibition by diazaborine [J].
de Boer, GJ ;
Pielage, GJA ;
Nijkamp, HJJ ;
Slabas, AR ;
Rafferty, JB ;
Baldock, C ;
Rice, DW ;
Stuitje, AR .
MOLECULAR MICROBIOLOGY, 1999, 31 (02) :443-450
[13]   NEW HETEROAROMATIC COMPOUNDS .20. DERIVATIVES OF 4,3-BORAZAROISOQUINOLINE [J].
DEWAR, MJS ;
DOUGHERTY, RC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (03) :433-&
[14]   PREPARATION AND ANTIBACTERIAL ACTIVITIES OF NEW 1,2,3-DIAZABORINE DERIVATIVES AND ANALOGS [J].
GRASSBERGER, MA ;
TURNOWSKY, F ;
HILDEBRANDT, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (08) :947-953
[15]  
GRONOWIT.S, 1971, ACTA PHARM SUEC, V8, P623
[16]  
GRONOWITZ S, 1971, ACTA PHARM SUEC, V8, P377
[17]  
Groziak M P, 2001, Am J Ther, V8, P321, DOI 10.1097/00045391-200109000-00005
[18]   Planar boron heterocycles with nucleic acid-like hydrogen-bonding motifs [J].
Groziak, MP ;
Chen, LY ;
Yi, L ;
Robinson, PD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (33) :7817-7826
[19]   The structural basis for hydrolysis resistance in the esters of (2-formylphenyl)boronic acid 2,4-dinitrophenylhydrazones [J].
Groziak, MP ;
Robinson, PD .
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2002, 67 (07) :1084-1094
[20]  
Groziak MP, 2000, PROG HET CH, V12, P1, DOI 10.1016/S0959-6380(00)80003-3